Matthäus Getlik
Max Planck Society(DE)Chemical Genomics Centre(DE)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Computational Drug Discovery Methods, Melanoma and MAPK Pathways, Cancer therapeutics and mechanisms, Protein Kinase Regulation and GTPase Signaling
Most-Cited Works
- → Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth(2015)484 cited
- → Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia(2015)284 cited
- → Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer(2009)255 cited
- → Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation(2010)218 cited
- → Erratum: Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia(2015)211 cited
- → Development of a Fluorescent-Tagged Kinase Assay System for the Detection and Characterization of Allosteric Kinase Inhibitors(2009)148 cited
- → Hybrid Compound Design To Overcome the Gatekeeper T338M Mutation in cSrc(2009)141 cited
- → A new screening assay for allosteric inhibitors of cSrc(2009)125 cited
- → Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design Approach(2015)112 cited
- → Structure-Based Optimization of a Small Molecule Antagonist of the Interaction Between WD Repeat-Containing Protein 5 (WDR5) and Mixed-Lineage Leukemia 1 (MLL1)(2016)88 cited